Ortivus AB (Sweden) Buy Hold or Sell Recommendation
ORTI-B Stock | SEK 3.11 0.02 0.64% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Ortivus AB Ser is 'Not Rated'. Macroaxis provides Ortivus AB buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ORTI-B positions. The advice algorithm takes into account all of Ortivus AB's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Ortivus AB's buy or sell advice are summarized below:
Real Value 0.0 | Hype Value 0.0 | Market Value 3.11 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Ortivus AB Ser given historical horizon and risk tolerance towards Ortivus AB. When Macroaxis issues a 'buy' or 'sell' recommendation for Ortivus AB Ser, the advice is generated through an automated system that utilizes algorithms and statistical models.
Ortivus |
Execute Ortivus AB Buy or Sell Advice
The Ortivus recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Ortivus AB Ser. Macroaxis does not own or have any residual interests in Ortivus AB Ser or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Ortivus AB's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Ortivus AB Trading Alerts and Improvement Suggestions
Ortivus AB Ser generated a negative expected return over the last 90 days | |
Ortivus AB Ser has high historical volatility and very poor performance | |
Ortivus AB Ser has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
The company has accumulated 2.04 M in total debt with debt to equity ratio (D/E) of 315.4, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Ortivus AB Ser has a current ratio of 0.69, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Ortivus AB until it has trouble settling it off, either with new capital or with free cash flow. So, Ortivus AB's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Ortivus AB Ser sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Ortivus to invest in growth at high rates of return. When we think about Ortivus AB's use of debt, we should always consider it together with cash and equity. | |
About 38.0% of Ortivus AB outstanding shares are owned by corporate insiders |
Ortivus AB Returns Distribution Density
The distribution of Ortivus AB's historical returns is an attempt to chart the uncertainty of Ortivus AB's future price movements. The chart of the probability distribution of Ortivus AB daily returns describes the distribution of returns around its average expected value. We use Ortivus AB Ser price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Ortivus AB returns is essential to provide solid investment advice for Ortivus AB.
Mean Return | -0.2 | Value At Risk | -5.26 | Potential Upside | 7.14 | Standard Deviation | 4.09 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Ortivus AB historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Ortivus AB Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Ortivus AB or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Ortivus AB's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Ortivus stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.2 | |
β | Beta against NYSE Composite | -0.06 | |
σ | Overall volatility | 4.09 | |
Ir | Information ratio | -0.08 |
Ortivus AB Volatility Alert
Ortivus AB Ser exhibits very low volatility with skewness of 1.29 and kurtosis of 4.63. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Ortivus AB's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Ortivus AB's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Ortivus AB Fundamentals Vs Peers
Comparing Ortivus AB's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Ortivus AB's direct or indirect competition across all of the common fundamentals between Ortivus AB and the related equities. This way, we can detect undervalued stocks with similar characteristics as Ortivus AB or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Ortivus AB's fundamental indicators could also be used in its relative valuation, which is a method of valuing Ortivus AB by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Ortivus AB to competition |
Fundamentals | Ortivus AB | Peer Average |
Return On Equity | 0.23 | -0.31 |
Return On Asset | 0.0822 | -0.14 |
Profit Margin | 0.08 % | (1.27) % |
Operating Margin | 0.1 % | (5.51) % |
Current Valuation | 232.78 M | 16.62 B |
Shares Outstanding | 42.6 M | 571.82 M |
Shares Owned By Insiders | 38.33 % | 10.09 % |
Shares Owned By Institutions | 30.45 % | 39.21 % |
Price To Earning | (17.16) X | 28.72 X |
Price To Book | 6.65 X | 9.51 X |
Price To Sales | 2.64 X | 11.42 X |
Revenue | 94.27 M | 9.43 B |
Gross Profit | 47.87 M | 27.38 B |
EBITDA | 12.71 M | 3.9 B |
Net Income | 9.21 M | 570.98 M |
Cash And Equivalents | 22.11 M | 2.7 B |
Cash Per Share | 0.20 X | 5.01 X |
Total Debt | 2.04 M | 5.32 B |
Debt To Equity | 315.40 % | 48.70 % |
Current Ratio | 0.70 X | 2.16 X |
Book Value Per Share | 0.80 X | 1.93 K |
Cash Flow From Operations | 7.77 M | 971.22 M |
Earnings Per Share | 0.17 X | 3.12 X |
Number Of Employees | 44 | 18.84 K |
Beta | 0.39 | -0.15 |
Market Capitalization | 216.54 M | 19.03 B |
Total Asset | 72.46 M | 29.47 B |
Working Capital | (19 M) | 1.48 B |
Current Asset | 29 M | 9.34 B |
Current Liabilities | 48 M | 7.9 B |
Z Score | 64.6 | 8.72 |
Net Asset | 72.46 M |
Ortivus AB Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Ortivus . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Ortivus AB Buy or Sell Advice
When is the right time to buy or sell Ortivus AB Ser? Buying financial instruments such as Ortivus Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Ortivus AB in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cancer Fighters Thematic Idea Now
Cancer Fighters
Biotech and medical diagnostic companies that work on researching drugs or manufacturing of medical and therapeutics equipment that is directly related to the research, treatment, and detection of cancer or cancer related diseases. The Cancer Fighters theme has 60 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cancer Fighters Theme or any other thematic opportunities.
View All Next | Launch |
Check out Ortivus AB Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for Ortivus Stock analysis
When running Ortivus AB's price analysis, check to measure Ortivus AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ortivus AB is operating at the current time. Most of Ortivus AB's value examination focuses on studying past and present price action to predict the probability of Ortivus AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ortivus AB's price. Additionally, you may evaluate how the addition of Ortivus AB to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Fundamental Analysis View fundamental data based on most recent published financial statements |